RETRACTION article

Front. Cell Dev. Biol., 17 August 2022

Sec. Mitochondrial Research

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.1014307

Retraction: Opa1 reduces hypoxia-induced cardiomyocyte death by improving mitochondrial quality control

Article metrics

View details

3k

Views

1,8k

Downloads

Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

The authors do not agree to this retraction.

This retraction was approved by the Chief Editors of Frontiers in Cell and Developmental Biology and the Chief Executive Editor of Frontiers.

Summary

Keywords

Post-infarction cardiac injury, OPA1, Mitochondrial quality control, Mitochondria, hypoxia

Citation

Frontiers Editorial Office (2022) Retraction: Opa1 reduces hypoxia-induced cardiomyocyte death by improving mitochondrial quality control. Front. Cell Dev. Biol. 10:1014307. doi: 10.3389/fcell.2022.1014307

Received

08 August 2022

Accepted

08 August 2022

Published

17 August 2022

Approved by

Amadou K. S. Camara, Medical College of Wisconsin, United States

Volume

10 - 2022

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

This article was submitted to Mitochondrial Research, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics